As of December 15, 2025, Diagnos Inc (ADK.V) reports a Forward P/E of N/A.
Forward P/E gauges the price investors pay for each dollar of anticipated earnings, offering insight into a stock's future valuation.
Comparing Diagnos Inc's Forward P/E to Peers
To better understand Diagnos Inc's position, it's useful to compare its Forward P/E against industry peers. Below are selected comparisons:
| Company | Forward P/E |
|---|---|
| Diagnos Inc (ADK.V) | - |
| Castlight Health Inc (CSLT) | 405.94 |
| Cerner Corp (CERN) | 28.83 |
| Omnicell Inc (OMCL) | 25.40 |
| NextGen Healthcare Inc (NXGN) | 21.55 |
| OptimizeRx Corp (OPRX) | 17.50 |
Compared to its competitors, Diagnos Inc's Forward P/E is difficult to compare due to insufficient data.